TG Therapeutics Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
20,478.20
55,781.30
62,948.60
78,252.90
118,476.00
173,482
Depreciation, Depletion & Amortization
1.10
3.90
15.50
63.00
82.40
88
Other Funds
-
-
104.20
-
-
16,706
Funds from Operations
14,975.10
29,013.10
46,756.70
70,363.20
102,328.30
156,688
Changes in Working Capital
4,150.80
6,046.80
2,070.50
8,775.90
8,568.80
27,763
Net Operating Cash Flow
10,824.20
35,059.90
44,686.10
61,587.30
93,759.50
128,925
Capital Expenditures
5.70
18.60
42.20
344.00
2.20
Purchase/Sale of Investments
4,919.90
18,336.70
24,643.70
26,889.30
8,206.30
Net Investing Cash Flow
4,925.60
18,355.30
24,685.90
26,545.30
8,208.50
Issuance/Reduction of Debt, Net
-
729.80
-
13.50
-
Net Financing Cash Flow
39,779.30
68,643.50
68,723.70
5,016.00
133,658.60
Net Change in Cash
24,029.50
15,228.30
648.30
30,026.00
31,690.70
Free Cash Flow
10,829.90
35,078.50
44,728.40
61,931.30
93,761.70
Change in Capital Stock
39,779.30
69,373.30
68,827.90
5,029.50
133,658.60
About TG Therapeutics
View Profile
